RHEUMATOLOGICAL IMMUNE-MEDIATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS BASED ON THE FDA ADVERSE EVENTS REPORTING SYSTEM

被引：0
|
作者：
Rodriguez-Pla, A. [1 ]
机构：
[1] Mayo Clin, Rheumatol, Scottsdale, AZ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1437
引用
收藏
页码：1824 / 1825
页数：2
相关论文
共 50 条
  • [1] Rheumatological Immune-Related Adverse Events of Immune Checkpoint Inhibitors Based on the FDA Adverse Event Reporting System
    Rodriguez-Pla, Alicia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 901 - 903
  • [2] Immune-mediated respiratory adverse events of checkpoint inhibitors
    Tabchi, Samer
    Messier, Christine
    Blais, Normand
    [J]. CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 269 - 277
  • [3] Rheumatological adverse events secondary to immune checkpoint inhibitors
    Garbarino, Maria Cecilia
    Manzano, Natalia
    Messina, Osvaldo
    Zylberman, Marcelo
    [J]. REUMATOLOGIA CLINICA, 2023, 19 (04): : 215 - 222
  • [4] Rheumatological Adverse Events of Cancer Therapy with Immune Checkpoint Inhibitors
    Guadalupe Cano-Cruz, Lilian
    Barrera-Vargas, Ana
    Mateos-Soria, Abigail
    Soto-Perez-de-Celis, Enrique
    Merayo-Chalico, Javier
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (02) : 113 - 121
  • [5] Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system
    Chen, Chen
    Zhang, Chenyu
    Jin, Ziyan
    Wu, Bin
    Xu, Ting
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 689 - 697
  • [6] Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system
    Chen Chen
    Chenyu Zhang
    Ziyan Jin
    Bin WU
    Ting XU
    [J]. International Journal of Clinical Pharmacy, 2022, 44 : 689 - 697
  • [7] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    [J]. UROLOGE, 2017, 56 (04): : 486 - 491
  • [8] Immune-related adverse events associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system
    Chen, Chen
    Wu, Bin
    Zhang, ChenYu
    Xu, Ting
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [9] Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors
    Gwynn, Morgan E.
    DeRemer, David L.
    Saunders, Katherine M.
    Parikh, Jigarkumar
    Bollag, Roni J.
    Clemmons, Amber B.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 647 - 654
  • [10] Risk factors for immune mediated adverse events with immune checkpoint inhibitors.
    Pelcovits, Ari
    Mistry, Hetal
    Chudasama, Rani
    Andrea, Sarah
    Khurshid, Humera
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345